Anticancer regimens containing third generation taxanes SB-T-121605 and SB-T-121606 are highly effective in resistant ovarian carcinoma model is a research paper published in Frontiers in Pharmacology (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01CA103314-21
Tumor -Targeting Chemotherapeutic Agents
National Institutes of Health
Grantová Agentura, Univerzita Karlova
Ministerstvo Školství, Mládeže a Tělovýchovy
Grantová Agentura České Republiky
FWCI
0.32
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals